A breath-taking collaboration at Navigation Park
Imspex Diagnostics and RedKnight Consultancy, two small-to-medium-sized enterprises (SMEs) in South Wales, along with 3 other partners, have been awarded a grant of €2.37m from Horizon 2020, the European Commission’s Research and Innovation Programme. The other partners include Gesellschaft für analytische Sensorsysteme G.A.S. (Germany), StatisticaMedica (Ireland), and University of Warwick (UK).
The application was developed between Impsex and RedKnight, both of which are located at Tŷ Menter, Navigation Park in Abercynon. Imspex, the project coordinator, are focused on the continuous development of their GC-IMS analytical instrument platform and its application in lab quality sensitive analysis on the field. RedKnight are grants and funding specialists who provide expert bid-writing services for proposals to programmes such as Horizon 2020. RedKnight will also be providing project management support for the duration of the two-year project.
Centred around the “BreathSpecTM” device, the project proposes a viable solution to the global problem of Antimicrobial Resistance (AMR) through the final developmental stages of an existing diagnostic device, which will allow a rapid, binary decision to be made on the need for antibiotic treatment, and with suitable optimisation will allow further differentiation and stratification to take place. The project includes technical developments to optimise its function, data acquisition for the development of the decision making analytical function and clinical validation.
Prof Peter Quantick, Director of RedKnight Consultancy Ltd, said:
“We established RedKnight in 2015 to address the growing need for expert bid-writers within the private sector, especially in Wales, where traditionally funding of this nature is accessed by the university sector. We identified the two main barriers for SMEs trying to access funding which were their lack of knowledge regarding what funding is available, as well as the time commitment it takes to develop a successful proposal. RedKnight help SMEs overcome these barriers and we’ll hopefully see more successes like the BreathSpecTM project in the near future.”
The world faces a growing epidemic of antibiotic resistance, however only two new classes of antibiotics have been brought to the market in the last 30 years. The discovery and development of new antibiotics is essential to maintain medical advances, but poses significant scientific, clinical, and financial challenges, particularly for antibiotics active against Gram-negative bacteria (such as E.coli). Such bacteria have effective barriers against drugs, making treatment difficult, resistance likely and development costs and risks high. In addition, any new antibiotics brought to the market would likely be used cautiously to delay the development of resistance, adding an additional financial challenge in recouping the development costs. The O’Neill Report on AMR identifies diagnostics as critical to the battle against antibiotic resistance.
Santi Dominguez, chief executive of IMSPEX Diagnostics Ltd, said:
“We are very excited by this funding, which will enable our organisation to collaborate with a first-class team and address the major social challenge of anti-microbial resistance with our new device. We have a vision of providing primary healthcare with a reliable, fast and simple solution for identifying bacterial or viral infection, optimising patient care and minimising antibiotic consumption. As a result of this project, we hope to be able to assist GPs and healthcare providers on a global scale. I congratulate the whole consortium on the success of this bid and would also like to thank the Welsh Government for its support with the bid preparation.”
“BreathSpecTM” addresses the above issues by producing reliable identification and quantification of key signature volatiles present in exhaled breath. It provides a non-invasive method for monitoring the volatile organic compounds (VOC) present in an individual’s exhaled breath (and subsequently the blood). It has long been recognised as having significant utility as a clinical test that can be used for early disease detection, monitoring, and potentially to diagnose specific bacterial infections for better, more targeted use of existing antibiotics.
To find out more about the BreathSpecTM project, please visit www.breathspec.com.
Thanks to Mathew Sutton (Cash4Clothes) and Andrew Williams (Bathrooms)
Thanks to Mathew Sutton (Cash4Clothes) and Andrew Williams (Bathrooms) tenants of our Pant Industrial Estate for organising the excellent fundraising event and to everyone who helped making this day special for little Mia. 5 year old Mia from Merthyr Tydfil was diagnosed with a rare type of cancer which affects babies and young children and this fundraising event was part of a wider drive to raise money for her clinical trials in the USA following extensive treatment in the UK. All our best wishes go to Mia and her family for a successful trial and speedy recovery
Join us for FAMILY FUN DAY at the Pant Industrial estate for MIA Chambers on 17th June
Please join us for a fun day in support of Mia Chambers, our little Rainbow Warrior Princess on Saturday 17th June at the Venture Wales carpark outside Cash 4 Clothes and Andrew Williams bathrooms on Pant Industrial estate, Dowlais for a fun day which will include:-
Rainbow Goodies Stall
Cake stall by Popty Bach
Fun & GAMES
Special Appearances throughout the day
And much more...
The fun starts at 10.30 am
Mia Chambers Journey - When nearly a dozen pupils at a Merthyr Tydfil primary school came down with a nasty sickness bug in April 2016, little Mia Chambers was initially thought to be one of the unfortunate victims. However, shortly after, her Mum, Kirsty, found a lump in little Mia’s tummy and her parents took her to their local GP, who then referred Mia to her nearest hospital.
Her condition was far more severe than her parents ever imagined and Mia was subsequently diagnosed with stage 4 high risk neuroblastoma. Four years old at the time, Mia started an aggressive regime of treatment including intensive chemotherapy, surgery, a stem cell transplant, radiotherapy and most recently, immunotherapy.
When Mia finishes immunotherapy, this will mark the end of her frontline treatment in the UK. Due to rates of relapse for neuroblastoma being high and relapsed neuroblastoma having low survival rates; Mia’s family would like for her to access an overseas based clinical trial as additional cancer therapy, in the hope that it will help prevent a dangerous relapse.
Unfortunately, clinical trials overseas are not NHS funded and can cost thousands of pounds, which is why Mia’s family have started to fundraise with “Solving Kids’ Cancer”. Supporting Mia’s fundraising campaign will help to ensure that Mia can access all the treatment options available to her, no matter where they exist in the world, to help her beat cancer.
A strong willed, determined and loving little girl, Mia loves nothing more than playing and interacting with others. “This monster will not beat us and we will do everything in our power to make sure it stays away” - Josh and Kirsty, Mia’s Mum and Dad.
Mia’s story can be followed via her Facebook page and more information can be found on the “Solving Kids’ Cancer” website at www.SolvingKidsCancer.org.uk.
We look forward to seeing you there!
Mayor of RCT declares new Abacare offices at Abercynon officially open
Mayor of RCT declares new Abacare offices at Abercynon officially open
THE MAYOR of Rhondda Cynon Taf (RCT), Councillor Rhys Lewis officially opened Abacare, the care agency’s new offices at Ty Cynon, Navigation Park, with a ribbon cutting ceremony.
Peter Angelides, CEO at the award-winning care provider, Abacare, which has recently won a significant tender in the area, said: “We were thrilled to have Mayor Rhys attend our official opening day and help to unveil our offices at the excellent Venture Wales Navigation Park office complex.
Gorwel – Venture Wales, The future of Wales after BREXit
Gorwel – Venture Wales
The future of Wales after BREXit
The consultation was undertaken in a dinner/workshop on the 28th June 2016 and refined by further email correspondence. The meeting was attended by a number of Wales leading business people and business organisations. There were no professional politicians present. In the meeting it was clear the attendees share concerns about what lies ahead.
Congratulations to Educ8 listed as top Welsh small company to work for in Sunday Times
Ben Sheppard, Grant Santos – Managing Director, Anne Lewis – Head of Finance, Colin Tucker – CEO, Tori Edwards – Head of WBL Operations, Tracey O’Neill – Head of Business Improvement, Jonathan Austin – Best Companies CEO
Abercynon based Educ8, a provider of learning and staff development services, has been announced as the top Welsh company to work for in the 2016 Sunday Times best small companies list.
Well done to Robert Chapman on his challenge to run the whole 1030 miles perimeter of Wales
Well done to Robert Chapman on his challenge to run the whole 1030 miles perimeter of Wales.
If you failed to recognise Robert Chapman the Chartered Surveyor and property consultant in the above picture, don’t worry as he is normally in a smart suit accompanied with his hard hat advising clients (including Venture Wales) on property matters.
Absolute Training & Assessing Ltd win Business Growth awards 2016
Absolute Training & Assessing is based at our Abercynon site, this fast growth training company scoops prestigious award in Cardiff. Our congratulations and best wishes go to Andrew Lewis and Rob Harris and the Absolute Training & Assessing team on seeing the efforts of their hard work rewarded by this award.